NCT06245915 2025-09-22AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Arsenal Biosciences, Inc.Phase 1/2 Active not recruiting37 enrolled
NCT01625260 2024-07-19A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder CancerAltor BioSciencePhase 1/2 Terminated12 enrolled 13 charts
NCT04464967 2021-05-12Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersNKGen Biotech, Inc.Phase 1/2 Withdrawn
NCT00006251 2020-01-21Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerFred Hutchinson Cancer CenterPhase 1/2 Completed21 enrolled
NCT00078858 2020-01-18Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 1/2 Completed37 enrolled
NCT00118326 2010-05-14Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseFred Hutchinson Cancer CenterPhase 1/2 Completed
NCT00010283 2010-04-02Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonFred Hutchinson Cancer CenterPhase 1/2 Completed